Oasis Capital won "Emerging Healthcare Investor of the Year" at the 2022 Future Healthcare 100 Conference.
Recently, VBData hosted the 2022 Future Healthcare 100 Conference and announced the "Future Healthcare 100" rankings. The selection process for this year's list launched in December 2021. Over a four-month submission period, the organizing committee collected nearly 1,300 company applications through self-nomination, institutional recommendations, and targeted outreach.
Recently, the 2022 Future Healthcare 100 Summit hosted by VBData concluded, with the "Future Healthcare 100" list unveiled. The selection process began in December 2021. Over a four-month nomination period, the organizing committee collected nearly 1,300 applications through corporate self-nominations, institutional recommendations, and targeted research.
The Future Healthcare 100 is the first list in China focused on innovative healthcare companies that have not yet gone public. Launched by VB100, VBData, and Eggshell Research Institute, it aims to identify Chinese healthcare innovators who truly represent the future, discover the core forces driving China's future healthcare industry, and accelerate innovation and transformation in the health sector. It is now the most closely watched annual selection in the life sciences and healthcare space among both industry and capital markets.
Among the honorees, Oasis Capital received the 2022 Future Healthcare 100 Pengcheng Award for "Emerging Healthcare Investor of the Year."
The world changes endlessly, and noise is everywhere. Oasis Capital will continue to uphold its top-down research methodology, combining the experience of ecosystem entrepreneurs to deliver clear signals to companies over the long term. We remain committed to demographic structure and technological innovation as our entry points, focusing on technology-enabled services in healthcare and enterprise software, and making long-term investments in the most vital entrepreneurs. Championing Vitality.
Click below for the full list: Future Healthcare 100
Oasis Capital is a new-generation Chinese venture capital firm dedicated to discovering the most vital entrepreneurs of the coming decade in China, growing alongside them, and creating long-term value. "Championing Vitality" is Oasis's vision and mission. This vitality is both the direction of structural transformation in our era and the resilience and evolutionary force of entrepreneurs themselves.
Oasis Capital focuses on early and growth-stage investments, with check sizes ranging from $3 million to $30 million. We concentrate on technology-enabled services, with particular emphasis on healthcare and enterprise software, supporting China's technology-driven upgrade of services.
